# Part-Time Remote Pharmacist in Minnesota Medical Cannabis Program > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/minnesota-medical-cannabis-pharmacist-roles-expanding/ > **Published:** 2026-04-09T15:13:03-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:26-04:00 > **Clinical Summary:** Explore Minnesota medical cannabis pharmacist roles expanding with remote opportunities, enhancing patient care and pharmacy integration. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyPharmacy Practice[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)MinnesotaHealthcare Integration Why This Matters Minnesota’s expansion of pharmacist roles in [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) represents a significant step toward integrating [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) into mainstream healthcare infrastructure. This signals growing state recognition that cannabis therapeutics require pharmaceutical-level oversight and patient counseling expertise. Clinical Summary Minnesota is actively recruiting pharmacists for its medical cannabis program, indicating expansion of pharmaceutical oversight in state-regulated [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). This reflects a broader trend of states incorporating traditional pharmacy practice standards into medical cannabis programs, including patient consultations, [drug interaction](https://cedclinic.com/glp-1-addiction-risk-reduction-benefits/) screening, and dispensing protocols. The remote aspect suggests Minnesota is adapting to workforce realities while maintaining clinical oversight standards. Dr. Caplan’s Take “I’ve long advocated that cannabis medicine needs the same pharmaceutical rigor as any other therapeutic intervention. Minnesota’s approach of bringing licensed pharmacists into the equation is exactly what responsible cannabis medicine looks like.” Clinical Perspective 🧠 Clinicians should view this as positive infrastructure development that may improve patient safety and therapeutic outcomes. Pharmacist involvement typically means better [drug interaction](https://cedclinic.com/glp-1-addiction-risk-reduction-benefits/) screening, more standardized dosing guidance, and professional monitoring of patient responses. This model may become a template for other states seeking to professionalize their medical cannabis programs. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Part-Time%20Remote%20Pharmacist%20%28Minnesota%20Medical%20Cannabis%20Program%29%20%7C%20Jobflarely%20%40drcaplan&url=https%3A//jobflarely.liveblog365.com/job/part-time-remote-pharmacist-minnesota-medical-cannabis-program-3)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//jobflarely.liveblog365.com/job/part-time-remote-pharmacist-minnesota-medical-cannabis-program-3)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Part-Time%20Remote%20Pharmacist%20%28Minnesota%20Medical%20Cannabis%20Program%29%20%7C%20Jobflarely%20--%20via%20%40drcaplan.bsky.social%20https%3A//jobflarely.liveblog365.com/job/part-time-remote-pharmacist-minnesota-medical-cannabis-program-3)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://jobflarely.liveblog365.com/job/part-time-remote-pharmacist-minnesota-medical-cannabis-program-3](https://jobflarely.liveblog365.com/job/part-time-remote-pharmacist-minnesota-medical-cannabis-program-3) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What topics does this cannabis news cover?](#What_topics_does_this_cannabis_news_cover) - [Why is this considered “notable clinical interest”?](#Why_is_this_considered_8220notable_clinical_interest8221) - [Is this related to a specific state’s cannabis program?](#Is_this_related_to_a_specific_state8217s_cannabis_program) - [How does this impact pharmacy practice?](#How_does_this_impact_pharmacy_practice) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #76 with “Notable Clinical Interest” status. This indicates emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What topics does this cannabis news cover? The article covers policy developments, pharmacy practice implications, and medical cannabis regulations. It appears to be specifically focused on developments in Minnesota. #### Why is this considered “notable clinical interest”? The “notable clinical interest” designation suggests this involves emerging findings or policy changes that could impact clinical practice. Healthcare providers should monitor these developments as they may affect [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) or treatment options. #### Is this related to a specific state’s cannabis program? Yes, this article specifically relates to Minnesota’s cannabis policies or medical cannabis program. The content likely discusses state-specific regulatory or policy changes affecting healthcare providers and patients. #### How does this impact pharmacy practice? The pharmacy practice tag indicates this news may affect how pharmacists handle cannabis-related medications or patient consultations. This could involve changes to dispensing procedures, regulations, or professional responsibilities in Minnesota. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Medical cannabis: Is the pharmacy sector ready to roll? – Chemist+Druggist](https://cedclinic.com/pharmacy-integration-medical-cannabis-readiness/) Explore how the pharmacy sector is adapting to medical cannabis integration and the evolving role of pharmacists. [Read More](https://cedclinic.com/pharmacy-integration-medical-cannabis-readiness/) [New medical cannabis clinic opens in the Highlands – WAVE 3](https://cedclinic.com/new-medical-cannabis-clinic-opens-highlands/) Learn about new medical cannabis clinics enhancing [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) and care in different regions. [Discover More](https://cedclinic.com/new-medical-cannabis-clinic-opens-highlands/) [Patient Advocate Team Lead Part-Time (Medical Cannabis) – LinkedIn](https://cedclinic.com/patient-advocate-roles-cannabis-medical-support/) Insights into part-time roles supporting medical cannabis patients, highlighting workforce trends. [Explore Roles](https://cedclinic.com/patient-advocate-roles-cannabis-medical-support/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).